Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 12-Jul-16 5:07 PM View:  | Kovner Bruce | Celator Pharmaceuticals Inc (NONE) | 12-Jul-16 | Disposition (change in control) | 2,155,970 | $30.25 | $65,218,200.00 | (100%) 2.16M to 0 | |
| 13-Jul-16 1:06 PM View: | Kollender Richard S Director | Celator Pharmaceuticals Inc (NONE) | 12-Jul-16 | Disposition (change in control) | 1,965,850 | $30.25 | $59,467,000.00 | (100%) 1.97M to 0 | |
| 12-Jul-16 4:32 PM View: | Vitullo Nicole Director | Celator Pharmaceuticals Inc (NONE) | 12-Jul-16 | Disposition | 2,401,520 | $30.25 | $72,646,096.00 | (100%) 2.4M to 0 | |
| 12-Jul-16 4:21 PM View: | Mayer Lawrence David See Remarks | Celator Pharmaceuticals Inc (NONE) | 12-Jul-16 | Disposition | 11,099 | $30.25 | $335,745.00 | (100%) 11.1K to 0 | |
| 12-Jul-16 5:00 PM View: | Valence Life Sciences Gp II... | Celator Pharmaceuticals Inc (NONE) | 12-Jul-16 | Disposition (change in control) | 1,039,110 | $30.25 | $31,433,000.00 | (88%) 1.18M to 143.99K | |
| 12-Jul-16 4:21 PM View: | Jackson Scott Thomas Chief Executive Officer Director | Celator Pharmaceuticals Inc (NONE) | 12-Jul-16 | Disposition | 301,518 | $30.25 | $9,120,920.00 | (100%) 301.52K to 0 | |
| 12-Jul-16 5:04 PM View: | Morenstein Scott D Director | Celator Pharmaceuticals Inc (NONE) | 12-Jul-16 | Disposition (change in control) Duplicate | 1,039,110 | $30.25 | $31,433,000.00 | (100%) 1.04M to 0 | |
| 12-Jul-16 5:00 PM View: | Valence Life Sciences Gp II... | Celator Pharmaceuticals Inc (NONE) | 12-Jul-16 | Disposition (change in control) | 143,986 | $30.25 | $4,355,580.00 | (100%) 143.99K to 0 | |
| 12-Jul-16 4:18 PM View: | Dougherty Michael R Executive Chairman Director | Celator Pharmaceuticals Inc (NONE) | 12-Jul-16 | Disposition | 20,000 | $30.25 | $605,000.00 | (100%) 20.0K to 0 | |
| 12-Jul-16 5:04 PM View: | Morenstein Scott D Director | Celator Pharmaceuticals Inc (NONE) | 12-Jul-16 | Disposition | 6,277 | $30.25 | $189,879.00 | (< 1%) 1.05M to 1.04M | |
| 12-Jul-16 4:24 PM View: | Powell Fred M VP and Chief Financial Officer | Celator Pharmaceuticals Inc (NONE) | 12-Jul-16 | Disposition | 156,064 | $30.25 | $4,720,940.00 | (100%) 156.06K to 0 | |
| 12-Jul-16 4:21 PM View: | Mayer Lawrence David See Remarks | Celator Pharmaceuticals Inc (NONE) | 12-Jul-16 | Disposition | 107,515 | $30.25 | $3,252,330.00 | (91%) 118.61K to 11.1K | |
| 07-Jul-16 6:02 PM View: | Jackson Scott Thomas Chief Executive Officer Director | Celator Pharmaceuticals Inc (NONE) | 07-Jul-16 | Option Exercise | 251,475 | $2.84 | $714,147.00 | 503% 50.04K to 301.52K | |
| 07-Jul-16 6:02 PM View: | Powell Fred M VP and Chief Financial Officer | Celator Pharmaceuticals Inc (NONE) | 06-Jul-16 | Option Exercise | 71,887 | $3.12 | $224,000.00 | 85% 84.18K to 156.06K | |
| 01-Jul-16 5:17 PM View: | Powell Fred M VP and Chief Financial Officer | Celator Pharmaceuticals Inc (NONE) | 29-Jun-16 | Gift | 1,665 | -- | -- | (2%) 85.84K to 84.18K | |
| 27-Jun-16 9:39 PM View: | Powell Fred M See Remarks | Celator Pharmaceuticals Inc (NONE) | 23-Jun-16 | Payment of Exercise | 2,491 | $30.15 | $75,103.60 | (3%) 88.33K to 85.84K | |
| 27-Jun-16 9:39 PM View: | Powell Fred M See Remarks | Celator Pharmaceuticals Inc (NONE) | 23-Jun-16 | Option Exercise | 56,875 | $1.32 | $75,075.00 | 181% 31.46K to 88.33K | |
| 22-Jun-16 2:33 PM View: | Valence Life Sciences Gp II... | Celator Pharmaceuticals Inc (NONE) | 21-Jun-16 | Gift | 28,000 | -- | -- | (2%) 1.21M to 1.18M | |
| 22-Jun-16 3:16 PM View: | Kovner Bruce | Celator Pharmaceuticals Inc (NONE) | 21-Jun-16 | Gift | 564,222 | -- | -- | 25% 2.25M to 2.81M | |
| 22-Jun-16 3:16 PM View: | Kovner Bruce | Celator Pharmaceuticals Inc (NONE) | 21-Jun-16 | Gift | 654,719 | -- | -- | (23%) 2.81M to 2.16M | |
| 22-Jun-16 2:33 PM View: | Valence Life Sciences Gp II... | Celator Pharmaceuticals Inc (NONE) | 21-Jun-16 | Gift | 84,503 | -- | -- | (7%) 1.3M to 1.21M | |
| 13-Jul-16 1:06 PM View: | Kollender Richard S Director | Celator Pharmaceuticals Inc (NONE) | 20-Jun-16 | Exercise (in-the money or at-the-money) | 87,879 | -- | -- | 5% 1.88M to 1.97M | |
| 17-Mar-16 4:59 PM View: | Mayer Lawrence David President and Head of Research | Celator Pharmaceuticals Inc (NONE) | 15-Mar-16 | Payment of Exercise | 12,081 | $8.94 | $108,004.00 | (9%) 130.69K to 118.61K | |
| 17-Mar-16 4:59 PM View: | Mayer Lawrence David President and Head of Research | Celator Pharmaceuticals Inc (NONE) | 15-Mar-16 | Option Exercise | 48,002 | $2.25 | $108,004.00 | 58% 82.69K to 130.69K | |
| 07-Dec-15 10:54 AM View: | Morenstein Scott D Director | Celator Pharmaceuticals Inc (NONE) | 03-Dec-15 | Purchase | 5,000 | $1.87 | $9,325.00 | 392% 1.28K to 6.28K | |
| 07-Oct-15 9:21 AM View: | Jackson Scott Thomas Chief Executive Officer Director | Celator Pharmaceuticals Inc (NONE) | 06-Oct-15 | Purchase | 14,450 | $1.74 | $25,143.00 | 41% 35.59K to 50.04K | |
| 05-Oct-15 4:05 PM View: | Powell Fred M VP and Chief Financial Officer | Celator Pharmaceuticals Inc (NONE) | 05-Oct-15 | Purchase | 13,700 | $1.78 | $24,386.00 | 77% 17.76K to 31.46K | |
| 02-Oct-15 8:02 PM View: | Valence Life Sciences Gp II... | Celator Pharmaceuticals Inc (NONE) | 01-Oct-15 | Purchase | 2,000 | $1.64 | $3,280.00 | < 1% 1.29M to 1.3M | |
| 02-Oct-15 8:02 PM View: | Valence Life Sciences Gp II... | Celator Pharmaceuticals Inc (NONE) | 30-Sep-15 | Purchase | 10,200 | $1.64 | $16,774.00 | < 1% 1.28M to 1.29M | |
| 28-May-15 4:01 PM View: | Mayer Lawrence David See Remarks | Celator Pharmaceuticals Inc (NONE) | 14-May-15 | Option Exercise | 55,000 | $2.25 | $123,750.00 | 199% 27.69K to 82.69K | |
| 27-Feb-15 5:19 PM View: | Jackson Scott Thomas Chief Executive Officer Director | Celator Pharmaceuticals Inc (NONE) | 25-Feb-15 | Grant | 22,593 | -- | -- | 174% 13.0K to 35.59K | |
| 27-Feb-15 5:14 PM View: | Mayer Lawrence David President and Head of Research | Celator Pharmaceuticals Inc (NONE) | 25-Feb-15 | Grant | 7,639 | -- | -- | 35% 21.56K to 29.2K | |
| 27-Feb-15 5:17 PM View: | Powell Fred M Chief Financial Officer | Celator Pharmaceuticals Inc (NONE) | 25-Feb-15 | Grant | 6,758 | -- | -- | 61% 11.0K to 17.76K | |
| 18-Nov-14 4:01 PM View: | Powell Fred M Chief Financial Officer | Celator Pharmaceuticals Inc (NONE) | 18-Nov-14 | Purchase | 6,000 | $2.20 | $13,200.00 | 120% 5.0K to 11.0K | |
| 18-Nov-14 4:00 PM View: | Jackson Scott Thomas Chief Executive Officer Director | Celator Pharmaceuticals Inc (NONE) | 18-Nov-14 | Purchase | 10,000 | $2.20 | $22,000.00 | 333% 3.0K to 13.0K | |
| 20-Nov-14 4:06 PM View: | Dougherty Michael R Director | Celator Pharmaceuticals Inc (NONE) | 18-Nov-14 | Purchase | 20,000 | $2.15 | $42,940.00 | 100% 0 to 20.0K | |
| 16-May-14 12:03 PM View: | Powell Fred M Chief Financial Officer | Celator Pharmaceuticals Inc (NONE) | 15-May-14 | Purchase | 2,500 | $2.50 | $6,240.00 | 100% 2.5K to 5.0K | |
| 12-Feb-14 8:39 PM View: | Morenstein Scott D Director | Celator Pharmaceuticals Inc (NONE) | 10-Feb-14 | Acquisition (other) Duplicate | 1,123,610 | -- | -- | 64% 1.77M to 2.89M | |
| 12-Feb-14 8:37 PM View: | Valence Life Sciences Gp II... | Celator Pharmaceuticals Inc (NONE) | 10-Feb-14 | Disposition (other) | 1,765,080 | -- | -- | (58%) 3.05M to 1.28M | |
| 12-Feb-14 8:39 PM View: | Morenstein Scott D Director | Celator Pharmaceuticals Inc (NONE) | 10-Feb-14 | Acquisition (other) | 1,277 | -- | -- | < 1% 2.89M to 2.89M | |
| 12-Feb-14 8:37 PM View: | Valence Life Sciences Gp II... | Celator Pharmaceuticals Inc (NONE) | 10-Feb-14 | Acquisition (other) | 1,123,610 | -- | -- | 64% 1.77M to 2.89M | |
| 12-Feb-14 8:39 PM View: | Morenstein Scott D Director | Celator Pharmaceuticals Inc (NONE) | 10-Feb-14 | Disposition (other) Duplicate | 1,765,080 | -- | -- | (61%) 2.89M to 1.12M | |
| 12-Feb-14 8:37 PM View: | Valence Life Sciences Gp II... | Celator Pharmaceuticals Inc (NONE) | 10-Feb-14 | Acquisition (other) | 159,786 | -- | -- | 6% 2.89M to 3.05M | |
| 17-Dec-13 4:10 PM View: | Powell Fred M VP and CFO | Celator Pharmaceuticals Inc (NONE) | 17-Dec-13 | Purchase | 2,500 | $3.50 | $8,750.00 | 100% 0 to 2.5K | |
| 17-Dec-13 4:07 PM View: | Jackson Scott Thomas Chief Executive Officer Director | Celator Pharmaceuticals Inc (NONE) | 17-Dec-13 | Purchase | 3,000 | $3.50 | $10,490.40 | 100% 0 to 3.0K | |
| 08-Nov-13 5:07 PM View: | Mayer Lawrence David President and Head of Research | Celator Pharmaceuticals Inc (NONE) | 06-Nov-13 | Option Exercise | 2,401 | $2.81 | $6,746.81 | 13% 19.16K to 21.56K | |
| 31-Jul-13 4:02 PM View: | Quaker Bio Ventures Lp 10% Owner | Celator Pharmaceuticals Inc (NONE) | 29-Apr-13 | Acquisition (other) | 49,434 | -- | -- | 3% 1.77M to 1.82M | |
| 31-Jul-13 4:02 PM View: | Quaker Bio Ventures Lp 10% Owner | Celator Pharmaceuticals Inc (NONE) | 29-Apr-13 | Acquisition (other) | 59,995 | -- | -- | 3% 1.82M to 1.88M | |
| 01-May-13 5:26 PM View: | Vitullo Nicole Director | Celator Pharmaceuticals Inc (NONE) | 29-Apr-13 | Acquisition (other) | 156,749 | -- | -- | 7% 2.24M to 2.4M | |
| 31-Jul-13 4:03 PM View: | Kollender Richard S Director | Celator Pharmaceuticals Inc (NONE) | 29-Apr-13 | Acquisition (other) | 109,429 | -- | -- | 6% 1.77M to 1.88M |
